Pro-Dex Inc (NASDAQ:PDEX)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on June 30, 2019. Pro-Dex Inc is engaged in designing, development and manufacturing of powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. Pro-Dex Inc has a market cap of $61.850 million; its shares were traded at around $15.31 with a P/E ratio of 15.78 and P/S ratio of 2.37.
For the last quarter Pro-Dex Inc reported a revenue of $7.00 million, compared with the revenue of $6.25 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $27.2 million, an increase of 21% from last year. For the complete 30-year financial data, please go here.. For the last five years Pro-Dex Inc had an average revenue growth rate of 19.7% a year.
The reported diluted earnings per share was 97 cents for the year, an increase of 162.2% from previous year. The Pro-Dex Inc had a decent operating margin of 18.37%, compared with the operating margin of 15.16% a year before. The 10-year historical median operating margin of Pro-Dex Inc is 5.36%. The profitability rank of the company is 5 (out of 10).
At the end of the fiscal year, Pro-Dex Inc has the cash and cash equivalents of $7.74 million, compared with $5.19 million in the previous year. The long term debt was $3.93 million, compared with $0.01 million in the previous year. The interest coverage to the debt is at a comfortable level of 22.7. Pro-Dex Inc has a financial strength rank of 8 (out of 10).
At the current stock price of $15.31, Pro-Dex Inc is traded at 264.5% premium to its historical median P/S valuation band of $4.20. The P/S ratio of the stock is 2.37, while the historical median P/S ratio is 0.66. The stock gained 58.63% during the past 12 months.
For the complete 20-year historical financial data of PDEX, click here.
This article first appeared on GuruFocus.